-
The Importance of Follow-up Screening
Terri Ann DiJulio, a long-time lung cancer survivor who has overcome three lung cancer diagnoses, talks about the importance of follow-up screenings for lung cancer, family history considerations, and...
IN THE SPOTLIGHT
-
HOPE Summit
Make friends and get savvy about life with lung cancer! Each year, LUNGevity Foundation brings together patients and caregivers to build friendships and learn from reliable experts... -
Finding Clinical Trials for Lung Cancer: Tools and Resources
Clinical trials are an important option for patients because the newest treatment approaches, not available otherwise, are being tested in them. Clinical trial research leads to... -
Fuel for the Future: Good Nutrition for the Lung Cancer Community
Learn valuable information about good nutrition that can help you live well through lung cancer treatment and beyond. Gain insight and tips from Oncology Dietitian Lori Bumbaco, MS... -
Researchers Make New Inroads for EGFR Exon20+ NSCLC Patients
While our bodies can have a wide range of naturally occurring, harmless mutations in different genes, some mutations, called driver mutations, are key to driving the development of... -
The Benefits of Palliative Care for People Living with Lung Cancer
Palliative care is supportive care that anticipates, prevents, and treats the symptoms and side effects of the disease and its treatment. It is intended to improve one's quality of... -
Shared Decision-Making, Self-Advocacy, and Dealing with Financial Toxicity
Cardinale Smith, MD, PhD, oncologist and associate professor at the Icahn School of Medicine at Mt. Sinai, explains how shared decision-making with one's healthcare team can create... -
The Healing Power of Stress, with Mike Verano
Mike Verano is a cancer survivor, author, and counselor with over 28 years of experience in the mental health field. Mike joins LUNGevity's Angela James to share concepts from his... -
Healing is an Art, with Genevieve De Renne
Genevieve De Renne is a caregiver and artist whose artwork has been featured on the cover of three recent issues of the Journal of Oncology Navigation & Survivorship. Genevieve... -
Pneumonitis: A Common Side Effect
In this video, nurse practitioner Lauren Welch, MSN, NP-C, AOCNP, from the Sarah Cannon Research Institute at Tennessee Oncology offers a quick review of pneumonitis - a common... -
Thriving with Cancer, with Dann Wonser
Dann Wonser, a 16-year lung cancer survivor and author of the book Second Wind – Thriving with Cancer, joins LUNGevity's Angela James to share learnings from his cancer journey and...
HOPE Summit
HOPE Summit
Rockville, MD
Make friends and get savvy about life with lung cancer!
Each year, LUNGevity Foundation brings together patients and caregivers to build friendships and learn from reliable experts in the lung cancer community.
This positive and hopeful environment, aptly named HOPE Summit, will take place from May 5-7, 2023, in Rockville, MD. And registration is free!
This year, LUNGevity is pleased to announce that Julie Larson, a licensed clinical social worker with a focus on helping people living…
Let Your Voice Be Heard!
Let Your Voice Be Heard!
We are collecting stories from patients, caregivers, friends, and family members! Tell us how lung cancer has affected your life. Email your story to us at support@lungevity.org. Thanks!
Finding Clinical Trials for Lung Cancer: Tools and Resources
Finding Clinical Trials for Lung Cancer: Tools and Resources
Clinical trials are an important option for patients because the newest treatment approaches, not available otherwise, are being tested in them. Clinical trial research leads to more advancements and potential treatment options, and the therapies used today were once tested in clinical trials. Continued progress is only possible if patients with lung cancer volunteer to participate in the clinical trial process.
There are many ongoing clinical trials testing new lung cancer treatments,…
The Importance of Follow-up Screening
The Importance of Follow-up Screening
Terri Ann DiJulio, a long-time lung cancer survivor who has overcome three lung cancer diagnoses, talks about the importance of follow-up screenings for lung cancer, family history considerations, and shared decision-making. The webinar is hosted by Amy Moore, PhD, LUNGevity’s VP of Global Engagement and Patient Partnerships.
RET, MET, and EGFR: An unusual tale of three oncogenes in lung cancer
RET, MET, and EGFR: An unusual tale of three oncogenes in lung cancer
LUNGevity's Upal Basu Roy, PhD, MPH, Executive Director, Research, discusses innovative research into RET+ NSCLC with patient advocates and the scientist conducting the studies. Panelists include Omaima Salous (diagnosed with RET+ NSCLC and co-founder of The Hamoui Foundation), Dr. Hilary Hammell (diagnosed with RET+ NSCLC and co-chair of RETpositive), and Dr. Tejas Patil (Assistant Professor, University of Colorado). The discussion focuses on Dr. Patil’s RET+ NSCLC research project and why…
Fuel for the Future: Good Nutrition for the Lung Cancer Community
Fuel for the Future: Good Nutrition for the Lung Cancer Community
Learn valuable information about good nutrition that can help you live well through lung cancer treatment and beyond.
Gain insight and tips from Oncology Dietitian Lori Bumbaco, MS, RDN, CSO, as she shares her expertise in an interactive presentation and answers nutrition questions from the community. Then watch a live cooking demo, where Lori prepares a healthy meal and snack and shares recipe ideas and cooking tips. You’ll also hear about additional support programs and resources for the…
Exon 20: What You Need to Know About this Rare Form of Lung Cancer
Osimertinib and Platinum Chemo Produces Unprecedented Results in NSCLC
Epidemiology, risk factors and impact of cachexia on patient outcome: Results from the Japanese Lung Cancer Registry Study
Epidemiology, risk factors and impact of cachexia on patient outcome: Results from the Japanese Lung Cancer Registry Study
Yale Cancer Center Expert Reports Significant Improvement in Survival for Lung Cancer Patients in the ADAURA Phase III Trial, involving AstraZeneca’s Targeted Therapy Drug, Tagrisso
Yale Cancer Center Expert Reports Significant Improvement in Survival for Lung Cancer Patients in the ADAURA Phase III Trial, involving AstraZeneca’s Targeted Therapy Drug, Tagrisso
Impact of Molecular Testing Using Next-Generation Sequencing in the Clinical Management of Patients with Non-Small Cell Lung Cancer in a Public Healthcare Hospital
Impact of Molecular Testing Using Next-Generation Sequencing in the Clinical Management of Patients with Non-Small Cell Lung Cancer in a Public Healthcare Hospital
Real-World Drug Development at the Targeted Therapies of Lung Cancer Meeting
Real-World Drug Development at the Targeted Therapies of Lung Cancer Meeting
The development of new treatments for any disease relies on the collaborative efforts of many different stakeholders, such as scientists, clinicians, patient advocacy groups, regulators, and pharmaceutical and biotech companies.
During scientific conferences that happen throughout the year, stakeholders cobble together opportunities to discuss the current state of treatments and strategize ways to bring emerging lifesaving treatments to patients.
Each year, there is one key conference…
EGFR Mutation Prevalence in Non-Small Cell Lung Cancer in West-European Patient Population
EGFR Mutation Prevalence in Non-Small Cell Lung Cancer in West-European Patient Population
Emotional Care for the Whole Family
Emotional Care for the Whole Family
A diagnosis of cancer has an impact on the entire family. Emotional support from family and friends can make a significant difference to the experience of survivorship, but knowing when, how, and in what way to offer support can be a challenge to figure out.
You may feel awkward and unsure about what to say. The moods and needs of the survivor and primary caregivers may change from moment to moment, making it hard to know when to step in. You may be balancing respecting their privacy with…
The Healing Power of Stress, with Mike Verano
The Healing Power of Stress, with Mike Verano
Mike Verano is a cancer survivor, author, and counselor with over 28 years of experience in the mental health field. Mike joins LUNGevity's Angela James to share concepts from his latest book, The Healing Power of Stress, as they relate to the caregiving experience, including a discussion on a concept he calls "posttraumatic caregiving." You can purchase Mike's book and find his other titles on Amazon.
Ask Your Oncologist the Right Questions
Ask Your Oncologist the Right Questions
Communication is critical to a positive doctor-patient relationship. Knowing the right questions to ask helps ensure you leave your appointments with the information and answers you need. Being prepared may also lessen anxiety and help provide a sense of control. Meeting with your oncologist, especially when first diagnosed or deciding on a treatment plan, are times when being prepared with questions is necessary.
LUNGevity has downloadable lists of questions that you can bring to…
For Caregivers: How to Support Your Loved One at Appointments
For Caregivers: How to Support Your Loved One at Appointments
Doctors' appointments are critical junctures in your loved one's lung cancer journey. They are a time to gather information and ask questions. We have created a list of tips for caregivers so that you feel prepared for your loved one's appointments, especially if you are new to the role.
Ask your loved one how they would like you to support them. It is important to honor your loved one's autonomy, and establishing what they want and need from you is key. Your role may start as note-taker,…
Targeted Drug Tagrisso Could Be Advance Against Lung Cancer
Thriving with Cancer, with Dann Wonser
Thriving with Cancer, with Dann Wonser
Dann Wonser, a 16-year lung cancer survivor and author of the book Second Wind – Thriving with Cancer, joins LUNGevity's Angela James to share learnings from his cancer journey and the tactics he's used to not only survive but thrive with lung cancer. Visit Dann's website to read his blog or purchase your own copy of Second Wind - Thriving with Cancer at www.dannwonser.com.
Healing is an Art, with Genevieve De Renne
Healing is an Art, with Genevieve De Renne
Genevieve De Renne is a caregiver and artist whose artwork has been featured on the cover of three recent issues of the Journal of Oncology Navigation & Survivorship. Genevieve joins LUNGevity's Angela James to share insights from her experience as a caregiver, especially how her art has helped her maintain purpose and power during her husband's lung cancer journey. You can view Genevieve’s cover art on the October, November, and December 2022 covers at www.jons-online.com/art-gallery.
Processing Grief, with Lois Hall
Processing Grief, with Lois Hall
Lois Hall is a practitioner and trainer in the Grief Recovery Method, an evidence-based program that helps individuals heal and process the emotional pain associated with grief. Lois joins LUNGevity's Angela James to discuss how all people are grievers and that hope for healing exists for us all. You can learn more about Lois at www.griefrecoverymethod.com/grms/lois-hall and access a free Grief Recovery Handbook at offers.griefrecoverymethod.com/two-step-order1614201563532.
One Patient's SCLC Journey
One Patient's SCLC Journey
Learn about small cell lung cancer through the eyes of a patient and his oncologist. Dr. Christine Lovly, internationally recognized medical oncologist, and Jeff Lackey, an SCLC survivor, discuss their journey, the importance of lung cancer screening, and key considerations when someone is newly diagnosed.
This session is moderated by Amy Moore, PhD, LUNGevity's Vice President of Global Engagement and Patient Partnerships. Christine M. Lovly, MD, PhD, is Associate Professor of Medicine and co…
Adjuvant Osimertinib Shows Long-Term DFS Benefit in Resected EGFR-Mutated NSCLC
Combinations Targeting EGFR and KRAS G12C May Advance NSCLC Treatment
Researchers Make New Inroads for EGFR Exon20+ NSCLC Patients
Researchers Make New Inroads for EGFR Exon20+ NSCLC Patients
While our bodies can have a wide range of naturally occurring, harmless mutations in different genes, some mutations, called driver mutations, are key to driving the development of cancer. There are many driver mutations. Researchers have been developing drugs that target specific driver mutations in lung cancer, creating therapies for those patients whose lung cancer harbors them.
Early Targeting of EGFR
In the early 2000s, EGFR was the first gene in non-small cell lung cancer (NSCLC) to be…
Targeted Therapy Options for Patients with EGFR Exon20+ NSCLC
Targeted Therapy Options for Patients with EGFR Exon20+ NSCLC
Researchers have made tremendous progress in treating lung cancer by identifying key mutations in genes that drive the growth of lung cancer. Once these “driver” mutations are identified, researchers can work to target these mutations with specific treatments, called targeted therapies.
FDA-approved targeted therapies exist for treating EGFR-positive NSCLC, or non-small cell lung cancer (NSCLC) patients whose tumors test positive for exon19 and exon21 L858R mutations in the EGFR (epidermal…
Shared Decision-Making, Self-Advocacy, and Dealing with Financial Toxicity
Shared Decision-Making, Self-Advocacy, and Dealing with Financial Toxicity
Cardinale Smith, MD, PhD, oncologist and associate professor at the Icahn School of Medicine at Mt. Sinai, explains how shared decision-making with one's healthcare team can create a treatment plan that aligns with the patient's goals.
This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc.
The Benefits of Palliative Care for People Living with Lung Cancer
The Benefits of Palliative Care for People Living with Lung Cancer
Palliative care is supportive care that anticipates, prevents, and treats the symptoms and side effects of the disease and its treatment. It is intended to improve one's quality of life and can be addressed at any stage from diagnosis forward.
This webinar features Estelamari Rodriguez, MD, MPH, thoracic oncologist at the Sylvester Comprehensive Cancer Center at the University of Miami. This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc.
Raise Your Voice: Speaking Up About Living With Lung Cancer
Raise Your Voice: Speaking Up About Living With Lung Cancer
An online panel discussion offers real-world suggestions and examples for ways to get the care and support you need. The discussion features Angela James, LUNGevity care navigator; Lavern McDonald, a teacher living with lung cancer; and Patricia Simmers, a nurse navigator. The panelists share their personal stories, challenges, and lessons learned through their journeys with lung cancer. This panel discussion was hosted by LUNGevity in collaboration with Novartis.
Science Spotlight: NSCLC Transformation into SCLC
Science Spotlight: NSCLC Transformation into SCLC
Take a behind-the-scenes look at how researchers study lung cancer. Join lung cancer researcher Triparna Sen, PhD, as she digs into what’s known about how EGFR-positive NSCLC cells transform into SCLC to escape targeted therapy treatment. SCLC transformation is a common resistance mechanism for multiple types of NSCLC, including EGFR, ALK, and RET.
This Facebook Live event is hosted by Amy Moore, PhD, LUNGevity’s Vice President of Global Engagements and Patient Partnerships. Dr. Sen is Co-…